In the past thirty years, social memory of the Eurasian youth has been influenced by many actors of the commerative space, who often pursue their own goals in the struggle to legitimize the new political order and their policies of the radical economic transformation. The results of their efforts should be taken into account in the implementation of one of the most important joint projects of the post-Soviet countries - Eurasian integration, because social memory of the youth is the most important resource for its success. The study aims at clarifying and evaluating the mechanisms for preserving information about the past, the peculiarities of the generation Y ideas about the common history and the current stage of the EAEU construction, which are present in the public discourse, and at revealing the relationship between attitudes to the past and to the Eurasian integration, the influence of social memory on the personal worldview, the forms and methods of its reconstruction in the interests of the post-Soviet countries interaction and efficiency of the politics of memory. The formation of social memory is defined as the activity of actors (individuals, groups, organizations, social institutions, communities) aimed at the interpretation of the collective past and common present by the youth of the countries participating in the Eurasian integration. The empirical object of the study - young citizens of the member states and candidates for joining the EAEU (18-38 years old), who live, study or work in Moscow. The article considers the respondents assessments of the contribution of each of the actors to the social memory formation and describes social memory of the generation Y as a set of views, feelings and moods reflecting the perception of the Soviet past and the common present. The authors insist on the purposeful policy of the leaders of the countries, participating in the Eurasian integration, to ensure the reconstruction of the youths social memory and the consolidation of societies.
Post-traumatic osteoarthritis (PTOA) is an inflammatory and degenerative disease that occurs as a result of the joint structures injury. It is a common pathology, accounting for approximately 12% of all cases of osteoarthritis (OA). PTOA often occurs in people of young productive age, progresses rapidly, causing chronic pain and increasing dysfunction. Individuals undergoing joint replacement for PTOA are, on average, 10 years younger than those with primary OA. The time interval from the moment of injury to the onset of typical PTOA radiological signs varies widely – from 1 year to 15–20 years.The main injuries that cause PTOA are intra-articular fractures, anterior cruciate ligament injuries, meniscus rupture and dislocation of the patella of the knee joint, joint dislocations with damage to the ligamentous apparatus of the ankle and shoulder joints.The pathogenesis of PTOA is determined by chronic inflammation accompanied by macrophage activation, hyperproduction of cytokines, primarily interleukin (IL) 1â, chemokines and growth factors, progressive destruction of joint tissue and degenerative changes (fibrosis, neoangiogenesis, osteophytosis).Pathogenetic treatment of PTOA, which would stop the progression of the disease, has not been developed. The possibility of using inhibitors of IL1â, IL6, inhibitors of tumor necrosis factor á, glucocorticoids, hyaluronic acid, autologous cell based therapy is under study. The control of pain and inflammation in PTOA requires the prescription of traditional drugs that are widely used in the practice of managing patients with primary OA. In particular, the use of symptomatic delayed-acting agents, such as the injectable form of chondroitin sulfate, seems to be appropriate.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.